The importance of therapeutic drug monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for hematopoietic stem cell transplantation (HSCT) in children.
第一作者:
Hundie,Tesfaye
第一单位:
Department of Medical Chemistry and Clinical Biochemistry, Division of Clinical Pharmacology, Faculty Hospital in Motol, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
作者:
医学主题词
佐剂, 免疫(Adjuvants, Immunologic);青少年(Adolescent);体重(Body Weight);白消安(Busulfan);儿童(Child);儿童, 学龄前(Child, Preschool);色谱法, 高压液相(Chromatography, High Pressure Liquid);二硫代氨基甲酸酯(Ditiocarb);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物监测(Drug Monitoring);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);婴儿(Infant);输注, 静脉内(Infusions, Intravenous);骨髓摘除激动剂(Myeloablative Agonists);移植预处理(Transplantation Conditioning)
DOI
10.12659/AOT.889933
PMID
24811685
发布时间
2016-02-10
- 浏览7
Annals of transplantation
214-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



